Contact this trialFirst, we need to learn more about you.
Antiandrogen
Tivozanib + Enzalutamide for Prostate Cancer
Recruiting2 awardsPhase 2
Boston, Massachusetts
This trial is testing whether a combination of two drugs, one of which is already approved to treat prostate cancer, is more effective in delaying the progression of disease than the approved drug used alone. The drugs work in different ways to fight the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service